Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Peptidomimetic and small-molecule uPA inhibitors hold promise as cancer therapeutics

March 29, 2001

Antitumor and antiangiogenic effects demonstrated for new VEGF-binding molecule

March 29, 2001

Profile, status of Lorus's lead cancer therapeutics discussed at AACR meeting

March 29, 2001

BioChem Pharma's Troxatyl enters late-stage clinical trials in AML patients

March 29, 2001

Enrollment closed in Atrix's phase III trial with four-month Leuprogel

March 29, 2001

Leo presents improved vitamin D analogues for cancer, psoriasis

March 28, 2001

Combinations of NSAID and EGF receptor kinase inhibitor for colonic polyps

March 28, 2001

Pharmacokinetic, toxicity data presented for VNP-40101M this week to AACR

March 28, 2001

Photodynamic therapy with MV-6401 for selectively destroying tumor vasculature

March 28, 2001

Phase II study of decitabine as MDS treatment enrolling patients

March 28, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...